Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
751.50 USD | +2.48% | +6.93% | +29.28% |
Fiscal Period: June | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 5.81B | 6.92B | 9.21B | 10.5B | 9.81B | |||||
Total Revenues | 5.81B | 6.92B | 9.21B | 10.5B | 9.81B | |||||
Cost of Goods Sold, Total | 2.45B | 2.77B | 3.59B | 4.22B | 3.93B | |||||
Gross Profit | 3.36B | 4.15B | 5.62B | 6.28B | 5.88B | |||||
Selling General & Admin Expenses, Total | 736M | 731M | 863M | 989M | 972M | |||||
R&D Expenses | 864M | 928M | 1.11B | 1.3B | 1.28B | |||||
Other Operating Expenses, Total | 1.6B | 1.66B | 1.97B | 2.29B | 2.25B | |||||
Operating Income | 1.76B | 2.49B | 3.65B | 3.99B | 3.63B | |||||
Interest Expense, Total | -160M | -157M | -160M | -297M | -311M | |||||
Interest And Investment Income | 21.65M | 8.93M | 8.7M | 74.1M | 161M | |||||
Net Interest Expenses | -139M | -148M | -152M | -223M | -151M | |||||
Currency Exchange Gains (Loss) | -4.24M | -5M | -3.92M | -233K | 7.27M | |||||
Other Non Operating Income (Expenses) | -16.66M | -4.18M | -6.5M | 5.06M | -10.42M | |||||
EBT, Excl. Unusual Items | 1.6B | 2.33B | 3.49B | 3.77B | 3.48B | |||||
Restructuring Charges | - | - | - | - | -70.47M | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | -257M | - | - | - | -193M | |||||
Gain (Loss) On Sale Of Investments | 297K | 26.97M | -306K | -986K | -103K | |||||
Gain (Loss) On Sale Of Assets | -1.9M | 4.42M | - | 29.69M | - | |||||
Asset Writedown | - | - | - | - | -26.4M | |||||
Other Unusual Items | -22.54M | - | - | -13.29M | - | |||||
EBT, Incl. Unusual Items | 1.32B | 2.36B | 3.49B | 3.79B | 3.19B | |||||
Income Tax Expense | 102M | 283M | 167M | 402M | 428M | |||||
Earnings From Continuing Operations | 1.22B | 2.08B | 3.32B | 3.39B | 2.76B | |||||
Net Income to Company | 1.22B | 2.08B | 3.32B | 3.39B | 2.76B | |||||
Minority Interest | 1.76M | 939K | -253K | -74K | - | |||||
Net Income - (IS) | 1.22B | 2.08B | 3.32B | 3.39B | 2.76B | |||||
Net Income to Common Incl Extra Items | 1.22B | 2.08B | 3.32B | 3.39B | 2.76B | |||||
Net Income to Common Excl. Extra Items | 1.22B | 2.08B | 3.32B | 3.39B | 2.76B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 7.76 | 13.49 | 22.07 | 24.28 | 20.41 | |||||
Basic EPS - Continuing Operations | 7.76 | 13.49 | 22.07 | 24.28 | 20.41 | |||||
Basic Weighted Average Shares Outstanding | 157M | 154M | 150M | 139M | 135M | |||||
Net EPS - Diluted | 7.7 | 13.37 | 21.92 | 24.15 | 20.28 | |||||
Diluted EPS - Continuing Operations | 7.7 | 13.37 | 21.92 | 24.15 | 20.28 | |||||
Diluted Weighted Average Shares Outstanding | 158M | 155M | 152M | 140M | 136M | |||||
Normalized Basic EPS | 6.38 | 9.45 | 14.49 | 16.91 | 16.07 | |||||
Normalized Diluted EPS | 6.33 | 9.37 | 14.39 | 16.82 | 15.97 | |||||
Dividend Per Share | 3.3 | 3.6 | 4.2 | 5.2 | 5.65 | |||||
Payout Ratio | 42.93 | 26.91 | 19.22 | 21.63 | 27.99 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 2.11B | 2.82B | 4.01B | 4.41B | 4.04B | |||||
EBITA | 1.98B | 2.69B | 3.88B | 4.25B | 3.87B | |||||
EBIT | 1.76B | 2.49B | 3.65B | 3.99B | 3.63B | |||||
EBITDAR | 2.14B | 2.85B | 4.05B | 4.45B | 4.09B | |||||
Total Revenues (As Reported) | 5.81B | 6.92B | 9.21B | 10.5B | 9.81B | |||||
Effective Tax Rate - (Ratio) | 7.72 | 11.99 | 4.79 | 10.6 | 13.42 | |||||
Current Domestic Taxes | 109M | 208M | 356M | 568M | 407M | |||||
Current Foreign Taxes | 86.37M | 121M | 165M | 189M | 160M | |||||
Total Current Taxes | 195M | 329M | 521M | 757M | 567M | |||||
Deferred Domestic Taxes | -27.92M | -33.14M | 11.25M | -233M | -113M | |||||
Deferred Foreign Taxes | -65.42M | -12.48M | -365M | -122M | -25.42M | |||||
Total Deferred Taxes | -93.34M | -45.62M | -354M | -355M | -139M | |||||
Normalized Net Income | 1B | 1.46B | 2.18B | 2.36B | 2.17B | |||||
Interest on Long-Term Debt | 160M | - | 160M | - | - | |||||
Non-Cash Pension Expense | 1.83M | 1.84M | 2.57M | 2.91M | 2.36M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 864M | 928M | 1.11B | 1.3B | 1.28B | |||||
Net Rental Expense, Total | 35.1M | 38.9M | 36.6M | 41.8M | 54.6M | |||||
Imputed Operating Lease Interest Expense | 12.87M | 13.76M | 9.1M | 15.47M | 21.11M | |||||
Imputed Operating Lease Depreciation | 22.23M | 25.14M | 27.5M | 26.33M | 33.49M | |||||
Stock-Based Comp., COGS (Total) | 14.68M | 17.36M | 21.11M | 29.1M | 35.94M | |||||
Stock-Based Comp., R&D Exp. (Total) | 23.53M | 23.34M | 27.62M | 44.7M | 60.12M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 73.17M | 71.14M | 78.19M | 97.62M | 117M | |||||
Total Stock-Based Compensation | 111M | 112M | 127M | 171M | 213M |